domingo, 16 de agosto de 2026

ACUTE ISCHEMIC STROKE 2026 Updated Early Management Based on the 2026 AHA/ASA Guideline

ACUTE ISCHEMIC STROKE 2026

Updated Early Management Based on the 2026 AHA/ASA Guideline

By DrRamonReyesMD ⚕️
EMS Solutions International

INTRODUCTION

Acute ischemic stroke (AIS) remains one of medicine's most important time-critical emergencies. Every avoidable delay may allow potentially salvageable brain tissue to progress toward irreversible infarction, permanent disability, or death.

In January 2026, the American Heart Association/American Stroke Association (AHA/ASA) published its updated guideline for the early management of patients with acute ischemic stroke.

Official guideline:

https://www.ahajournals.org/guidelines/acute-ischemic-stroke

Full scientific publication:

https://www.ahajournals.org/doi/10.1161/STR.0000000000000513

DOI:

https://doi.org/10.1161/STR.0000000000000513

The document replaces the 2018 guideline and its 2019 update and introduces important changes spanning prehospital stroke systems, intravenous thrombolysis, endovascular thrombectomy, physiologic management and pediatric stroke.

1. TIME IS BRAIN — BUT MODERN STROKE CARE IS ALSO ABOUT TISSUE

The operational pathway remains:

RECOGNIZE → ACTIVATE → TRANSPORT → IMAGE → REPERFUSE

Every avoidable delay should be eliminated.

The Last Known Well (LKW) must be accurately established and documented.

For wake-up strokes, the time of awakening should not automatically be interpreted as the actual stroke onset.

2. PREHOSPITAL RECOGNITION

Sudden focal neurological dysfunction should be considered stroke until proven otherwise.

Important findings include:

facial weakness;
unilateral arm or leg weakness;
aphasia;
dysarthria;
visual field loss;
gaze deviation;
acute ataxia;
unilateral sensory loss;
sudden severe balance impairment;
cortical deficits;
unexplained alteration in consciousness.

Prehospital stroke scales can support stroke recognition and estimation of possible large-vessel occlusion (LVO), but they do not replace clinical assessment or vascular imaging.

3. CHECK GLUCOSE EARLY

Point-of-care glucose should be obtained rapidly.

Hypoglycemia is an important stroke mimic and should be corrected promptly.

The 2026 guideline also delivers an important message regarding hyperglycemia:

intensive glucose lowering to 80–130 mg/dL is not recommended to improve neurological outcome.

It does not provide clinical benefit and increases the risk of severe hypoglycemia.

4. ABC STABILIZATION WITHOUT DELAYING REPERFUSION

Immediate assessment should include:

Airway — Breathing — Circulation.

Hypoxemia should be corrected.

Routine supplemental oxygen in adequately oxygenated patients should not become a distraction from definitive stroke management.

Identify and treat:

hypoxemia;
hypotension;
hypovolemia;
hypoglycemia;
hyperthermia;
major metabolic abnormalities;
clinically significant arrhythmias.

Hypotension is particularly undesirable because cerebral perfusion to vulnerable ischemic penumbra may fall further.

5. EMS DESTINATION STRATEGY

The 2026 guideline refines prehospital destination management.

Stroke transport should no longer be reduced to a universal rule of taking every patient to the nearest thrombolysis-capable hospital.

Destination decisions should consider:

transport distance;
additional transport time;
probability of LVO;
IV thrombolysis capability;
EVT capability;
interhospital transfer performance;
regional stroke-system organization.

In efficient systems with rapid secondary transfers, bypassing a proficient thrombolysis-capable center may provide no benefit.

Where transfer systems are inefficient, however, direct transport to the closest appropriate EVT-capable center should be considered.

Stroke-system architecture therefore becomes part of the treatment itself.

6. MOBILE STROKE UNITS

The 2026 guideline supports implementation of Mobile Stroke Units (MSUs) where feasible.

MSUs may combine:

specialized personnel;
mobile CT;
tele-neurology;
point-of-care laboratory testing;
prehospital thrombolysis capability.

The concept effectively moves part of the stroke center toward the patient rather than waiting for the patient to reach the stroke center.

7. EMERGENCY NEUROIMAGING

Potential reperfusion candidates require immediate brain imaging.

The standard initial examination remains:

noncontrast head CT.

Its immediate objectives include:

excluding intracranial hemorrhage;
identifying ischemic changes;
estimating established tissue injury;
supporting reperfusion decisions.

When LVO is suspected, rapid vascular imaging—commonly CT angiography of the head and neck—becomes essential.

Selected late-window patients may additionally require:

CT perfusion;
MR perfusion;
diffusion-weighted MRI;
DWI–FLAIR mismatch assessment.

8. DO NOT DELAY THROMBOLYSIS FOR UNNECESSARY ADVANCED IMAGING

For an eligible patient presenting within 4.5 hours with a disabling neurological deficit, IV thrombolysis should not be unnecessarily delayed to obtain additional multimodal imaging.

In the conventional treatment window:

rapid diagnosis + adequate initial imaging + exclusion of contraindications → reperfusion.

Minutes matter.

9. IV THROMBOLYSIS: ALTEPLASE OR TENECTEPLASE

A major 2026 development is the position of tenecteplase (TNK).

The guideline endorses either:

ALTEPLASE

TENECTEPLASE

for IV thrombolysis within the 4.5-hour treatment window in appropriately selected patients.

International randomized evidence supporting tenecteplase, combined with its pharmacological and logistical characteristics, has strengthened its role.

A major practical advantage is:

single IV bolus administration.

This may simplify emergency department treatment, Mobile Stroke Unit operations, interhospital transfer and workflows preceding EVT.

10. A LOW NIHSS DOES NOT NECESSARILY MEAN A MINOR STROKE

A patient may have a relatively low NIHSS while experiencing a profoundly disabling neurological deficit.

Examples include:

significant aphasia;
hemianopia;
disabling dominant-hand weakness;
gait-preventing weakness;
occupation-critical neurological dysfunction.

The 2026 guideline emphasizes rapid thrombolytic treatment for eligible patients with disabling deficits within 4.5 hours regardless of NIHSS score.

The key principle is:

treat disability, not merely a number.

11. NON-DISABLING STROKE

Patients with truly non-disabling deficits, such as selected isolated sensory syndromes, have not demonstrated sufficient benefit from IV thrombolysis in randomized trials.

For appropriately selected patients in this category:

dual antiplatelet therapy (DAPT)

is preferred over IV thrombolysis.

The distinction is crucial:

minor stroke is not synonymous with non-disabling stroke.

12. EXTENDED-WINDOW THROMBOLYSIS

The 4.5-hour threshold is no longer an absolute biological boundary for every patient.

The 2026 guideline supports IV thrombolysis in selected patients with:

unknown onset;
wake-up stroke;
approximately 4.5–9 hours from symptom onset;

when advanced imaging demonstrates appropriate tissue characteristics.

Selection may include:

DWI–FLAIR mismatch

perfusion-based mismatch.

Modern stroke care therefore increasingly moves from:

clock-based selection

toward:

time + tissue-based selection.

13. ENDOVASCULAR THROMBECTOMY

EVT is an established standard of care for appropriately selected patients with LVO.

Selection integrates:

occlusion location;
vascular territory;
time from LKW;
NIHSS;
prestroke functional status;
infarct extent;
salvageable tissue;
vascular anatomy.

Treatment should proceed rapidly once eligibility has been established.

14. LARGE ISCHEMIC CORE: A MAJOR PARADIGM SHIFT

Historically, patients with extensive established ischemic injury were frequently excluded from thrombectomy.

Recent randomized trials have changed this approach.

Selected patients with larger ischemic cores can still obtain meaningful functional benefit from EVT.

Therefore:

large core ≠ automatic therapeutic futility.

Clinical, vascular and imaging findings must be integrated rather than using infarct size alone as an automatic exclusion criterion.

15. BASILAR ARTERY OCCLUSION

The 2026 guideline provides a strong recommendation for EVT in appropriately selected patients with:

basilar artery occlusion + NIHSS ≥10 + presentation within 24 hours.

Contemporary randomized evidence demonstrates improved functional outcomes compared with medical therapy alone in this population.

This represents an important evolution in posterior-circulation stroke management.

16. BRIDGING THERAPY

When a patient is eligible for both IV thrombolysis and EVT, eligible thrombolysis should not be withheld merely because thrombectomy is planned.

Conceptually:

IV THROMBOLYSIS → EVT

when both treatments are indicated.

Conversely, EVT should not be unnecessarily delayed while waiting to determine whether the neurological deficit improves after IV thrombolysis.

17. BLOOD PRESSURE: PRESERVE CEREBRAL PERFUSION

Acute hypertension following ischemic stroke may partly represent a compensatory response supporting perfusion of threatened brain tissue.

Aggressive normalization can therefore be harmful.

Before IV thrombolysis

Blood pressure generally needs to be reduced to:

<185/110 mmHg

before thrombolytic administration.

Subsequent monitoring and management should follow reperfusion protocols.

Without reperfusion therapy

In appropriately selected patients without another compelling indication for urgent BP reduction, permissive hypertension may be appropriate.

Abrupt reductions should be avoided.

18. DO NOT ROUTINELY TARGET SBP <140 mmHg AFTER REPERFUSION

Recent evidence has materially changed post-reperfusion blood-pressure management.

Intensive reduction of systolic BP to:

<140 mmHg

does not improve functional outcome following IV thrombolysis and may cause harm after EVT.

Even after complete angiographic reperfusion—such as TICI 3 flow—routine intensive lowering below 140 mmHg is not recommended.

Management should instead avoid:

hypotension;
excessive hypertension;
abrupt BP reductions;
major BP variability.

19. ANTITHROMBOTIC THERAPY

Antithrombotic medication does not replace reperfusion therapy when reperfusion is indicated.

The guideline specifically advises against adjunctive antithrombotic agents such as:

argatroban;
eptifibatide;

for the purpose of enhancing outcomes following IV thrombolysis.

Available evidence has not demonstrated clinical benefit.

20. TEMPERATURE MANAGEMENT

Fever following stroke is associated with poorer outcomes.

Hyperthermia should therefore trigger:

temperature management;
evaluation for infection;
assessment for aspiration;
investigation of other systemic causes.

Maintaining appropriate physiological homeostasis remains an important component of neuroprotection.

21. DYSPHAGIA AND ASPIRATION PREVENTION

Swallowing should be assessed before oral food, fluids or medications are administered.

Poststroke dysphagia substantially increases the risk of:

aspiration;
pneumonia;
dehydration;
malnutrition.

A structured swallow screening pathway should therefore be part of early stroke care.

22. ORGANIZED STROKE-UNIT CARE

Whenever possible, patients with acute stroke should be managed in organized stroke units.

These environments facilitate:

serial neurological assessment;
hemodynamic monitoring;
early recognition of deterioration;
aspiration prevention;
cerebral edema surveillance;
complication management;
appropriate mobilization;
rehabilitation assessment;
etiologic investigation;
early secondary prevention.

23. NEUROLOGICAL DETERIORATION IS AN EMERGENCY

Any significant neurological deterioration requires immediate reassessment.

Potential causes include:

hemorrhagic transformation;
vessel reocclusion;
infarct progression;
cerebral edema;
recurrent embolization;
seizure;
hypoglycemia;
hypoxemia;
metabolic disturbances;
hypotension.

Repeat emergency neuroimaging may be required.

24. INTERHOSPITAL TRANSFER: DOOR-IN–DOOR-OUT MATTERS

Patients requiring EVT who initially present to a non-EVT hospital should undergo expedited transfer.

The guideline emphasizes systems designed to reduce Door-In–Door-Out (DIDO) time.

Regional networks should establish:

predetermined transfer agreements;
direct communication pathways;
rapid acceptance;
priority transport;
electronic imaging transfer;
standardized stroke protocols.

Rapid diagnosis loses much of its value if the patient subsequently spends hours waiting for transfer.

25. PEDIATRIC ACUTE ISCHEMIC STROKE

For the first time, the AHA/ASA AIS guideline includes specific recommendations addressing pediatric acute ischemic stroke.

Although pediatric AIS is uncommon, its consequences may be devastating.

The guideline emphasizes:

early recognition;
rapid specialized activation;
timely neuroimaging;
multidisciplinary assessment;
consideration of thrombolytic therapy in carefully selected patients;
potential benefit of EVT in selected children with LVO.

Because pediatric randomized evidence remains substantially more limited than adult evidence, specialized multidisciplinary decision-making remains critical.

26. 2026 OPERATIONAL ALGORITHM

SUSPECTED ACUTE STROKE

↓

ABC + SpO₂ + point-of-care glucose + establish LKW

↓

Stroke assessment / determine disabling deficit

↓

Pre-notify Stroke Center

↓

Emergency noncontrast CT

↓

HEMORRHAGE?

YES → intracranial hemorrhage pathway

NO → continue AIS pathway

↓

DISABLING DEFICIT AND ≤4.5 HOURS?

YES → evaluate IV thrombolysis

Alteplase OR tenecteplase

↓

SUSPECTED LVO?

CTA head/neck

↓

EVT CANDIDATE?

Immediate thrombectomy / emergency transfer

↓

EXTENDED WINDOW / WAKE-UP STROKE

Advanced imaging → evaluate salvageable tissue → IVT/EVT when appropriate

↓

POST-REPERFUSION

Stroke Unit + neurological monitoring + BP + glucose + temperature + swallowing assessment + complication prevention

27. TEN PRACTICE-CHANGING MESSAGES FOR 2026

Mobile Stroke Units are supported where feasible.
EMS destination decisions should reflect regional stroke-system performance and may favor direct transport to an EVT-capable center.
Alteplase or tenecteplase may be used for eligible IV thrombolysis patients within 4.5 hours.
A disabling deficit should be treated rapidly even when the NIHSS is low.
In truly non-disabling stroke, DAPT is preferred over IV thrombolysis in appropriate patients.
Selected unknown-onset and 4.5–9-hour strokes may receive thrombolysis using advanced imaging selection.
EVT eligibility has expanded to selected patients with large ischemic cores.
Selected patients with basilar artery occlusion, NIHSS ≥10 and presentation within 24 hours have a strong indication for EVT.
Intensive glucose targeting of 80–130 mg/dL is not recommended to improve neurological outcome.
Intensive post-reperfusion SBP reduction to <140 mmHg is not routinely recommended and may be harmful following EVT.

CONCLUSION

The 2026 AHA/ASA guideline consolidates a major evolution in acute ischemic stroke care.

Modern reperfusion is no longer governed by the clock alone.

Clinical decisions increasingly integrate:

TIME + CLINICAL DEFICIT + VESSEL + TISSUE + SYSTEM OF CARE.

Tenecteplase now occupies a central position alongside alteplase; imaging can extend treatment opportunities beyond conventional time windows; EVT eligibility has expanded to selected large-core and basilar-occlusion patients; and physiological management increasingly avoids excessively aggressive blood-pressure and glucose reduction.

The operational objective remains simple:

identify salvageable brain tissue and restore perfusion before that tissue becomes irreversible infarction.

SCIENTIFIC SOURCES & OFFICIAL RESOURCES

AHA/ASA — 2026 Acute Ischemic Stroke Guidelines
https://www.ahajournals.org/guidelines/acute-ischemic-stroke

Prabhakaran S, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026.
https://www.ahajournals.org/doi/10.1161/STR.0000000000000513

Official DOI
https://doi.org/10.1161/STR.0000000000000513

AHA Professional Heart Daily — Guideline Summary
https://professional.heart.org/en/science-news/2026-guideline-for-the-early-management-of-patients-with-acute-ischemic-stroke

AHA — Top Things to Know: 2026 AIS Guideline
https://professional.heart.org/en/science-news/2026-guideline-for-the-early-management-of-patients-with-acute-ischemic-stroke/top-things-to-know

AHA Professional Heart Daily — Guideline Hub and implementation resources
https://professional.heart.org/en/guidelines-statements/2026-guideline-for-the-early-management-of-patients-with-acute-ischemic-strokestr0000000000000513

By DrRamonReyesMD ⚕️
EMS Solutions International
Scientific Update 2026

Educational material intended for healthcare professionals. Individual clinical decisions should reflect patient-specific factors, local protocols, neuroimaging availability and regional stroke-system capabilities.

VISITAS RECIENTES

AUTISMO TEA PDF

We Support The Free Share of the Medical Information

Enlaces PDF por Temas

Nota Importante

Niveles de Alerta Antiterrorista en España. Nivel Actual 4 de 5.